Ravi Patel

Title: Inventor Spotlight: Ravi Patel - Pioneer in Pharmaceutical Stabilization

Introduction

Ravi Patel, an accomplished inventor based in Anand, India, has made significant contributions to the field of pharmaceuticals. His innovative work focuses on improving the stability of critical medications, particularly phenobarbital sodium, an essential drug used in the treatment of neonatal seizures.

Latest Patents

Ravi's noteworthy patent, titled "Stabilization of Phenobarbital Sodium for Injection," introduces a lyophilized pharmaceutical composition that addresses the hydrolytic instability of phenobarbital and its salts. The invention encompasses an aqueous solution for injection that can be reconstituted from the lyophilized composition, demonstrating remarkable stability for a minimum of two years under storage conditions. The composition allows for an ethanol content ranging from 5000 ppm to 70000 ppm, ensuring that total impurities remain below 0.5%. This advancement in drug formulation is crucial for enhancing the safety and efficacy of phenobarbital treatment in neonates.

Career Highlights

Ravi Patel is currently affiliated with Sun Pharma Advanced Research Company Limited, a leading pharmaceutical firm known for its focus on innovative research and development. His role has allowed him to leverage his skills in pharmaceutical sciences, ultimately resulting in impactful innovations that can save lives.

Collaborations

Throughout his career, Ravi has collaborated with talented colleagues, including Malay Shah and Bhushan Borole. Together, they foster a dynamic environment of creativity and technical expertise within their organization, contributing to the advancement of pharmaceutical formulations and enhancing patient care.

Conclusion

As a forward-thinking inventor, Ravi Patel exemplifies the spirit of innovation within the pharmaceutical industry. His patent on the stabilization of phenobarbital sodium not only showcases his dedication to enhancing medical treatments but also has the potential to significantly improve the quality of life for those affected by neonatal seizures. With continued research and collaboration, Ravi is poised to make even greater strides in the field of pharmaceutical sciences.